Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 3Immunoglobulin Light-chain Amyloidosis 2Neoplasms 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Amyloidosis 1

Interventions

Cyclophosphamide 15fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 12Cyclosporine 12Filgrastim 10Whole-Body Irradiation 9Mycophenolic Acid 9Busulfan 7Antilymphocyte Serum 7Melphalan 5fludarabine 4Radiotherapy 4Psychiatric Rehabilitation 4Methylprednisolone 4Methotrexate 4Etoposide 4Cord Blood Stem Cell Transplantation 4Therapeutics 3Rituximab 3Granulocyte Colony-Stimulating Factor 3Aprepitant 3Analgesia 3plerixafor 2Tacrolimus 2Ondansetron 2Magnetic Resonance Spectroscopy 2Flow Cytometry 2Dexamethasone 2Carmustine 2Calcium Dobesilate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Mantle-Cell × pomalidomide × Clear all
NCT07257510 2025-12-02

Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma

Peking University Third Hospital

Phase NA Recruiting
34 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡